Welcome to the AOAAM Addiction Medicine Board Certification Review Course! This session is a review of the genetic underpinnings of the individual susceptibility and development of addiction. This will be tied into the potential
environmental and epigenetic influences on genetics. Flowing from there will be a review of the current understanding of the neurobiology of addiction, from first reward to the development of the disease.
This session reviews the epidemiology of opioid use disorder and opioid overdose deaths, diagnosis of opioid use disorder, opioid intoxication, and opioid withdrawal, in addition to treatments for opioid withdrawal, and medications for opioid
use disorder.
This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options.
This session reviews the epidemiology of cannabis use disorder, diagnosis of cannabis use disorder, cannabis intoxication, and cannabis withdrawal. Medical marijuana policies and legalization of cannabis will be reviewed.
During this course there will be a review of the epidemiology of alcohol use disorders. There will information on the individual susceptibility to the disease and how understanding this can lead to individualize prevention. The
screening for and brief intervention of alcohol use, will be reviewed along with the biologic markers of the disease. Treatment of alcohol use disorders will be reviewed from current withdrawal recommendations to post abstinent chronic
care.
Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical
manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder.
